RTI Surgical Inc. (RTIX) Trading 2.5% Higher
RTI Surgical Inc. (NASDAQ:RTIX) shares traded up 2.5% during mid-day trading on Thursday . The stock traded as high as $3.33 and last traded at $3.29, with a volume of 72,158 shares. The stock had previously closed at $3.21.
Several research analysts have issued reports on the company. Zacks Investment Research lowered RTI Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, June 29th. Craig Hallum lowered RTI Surgical from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $6.00 to $4.00 in a research note on Thursday, July 28th.
The firm has a 50-day moving average of $3.36 and a 200-day moving average of $3.70. The company has a market cap of $196.42 million and a PE ratio of 47.89.
RTI Surgical (NASDAQ:RTIX) last issued its quarterly earnings results on Wednesday, July 27th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of $0.03 by $0.08. The firm earned $67.60 million during the quarter, compared to the consensus estimate of $66.52 million. The company’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same period last year, the firm posted $0.04 earnings per share. On average, equities research analysts forecast that RTI Surgical Inc. will post $0.10 earnings per share for the current fiscal year.
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.